Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. 1978

R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
August 1979, Annals of the rheumatic diseases,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
February 1986, British journal of rheumatology,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
January 2007, Clinical and experimental rheumatology,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
August 1997, The Journal of rheumatology,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
February 1976, Klinische Wochenschrift,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
June 2015, Australian prescriber,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
January 2010, Acta reumatologica portuguesa,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
January 1960, Bollettino - Societa medico chirurgica Cremona,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
November 2014, BMC musculoskeletal disorders,
R S Amos, and R A Crockson, and A P Crockson, and L Walsh, and B McConkey
May 2004, The Journal of rheumatology,
Copied contents to your clipboard!